Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kleber

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2006
Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)A D Wagner, P Buechner-Steudel, A Wein, et al.
British Journal of Cancer|November 12, 2009
Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trialsA D Wagner, P Buechner-Steudel, M Moehler, et al.
The Journal of Clinical Investigation|June 12, 2020
Auxiliary trafficking subunit GJA1-20k protects connexin-43 from degradation and limits ventricular arrhythmiasShaohua Xiao, Daisuke Shimura, Rachel Baum, et al.
Journal of Molecular and Cellular Cardiology|November 13, 2023
Determinants of electrical propagation and propagation block in Arrhythmogenic CardiomyopathyQianru Jin, Keel Yong Lee, Zoja Selimi, et al.
JCI Insight|May 13, 2016
Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathyStephen P Chelko, Angeliki Asimaki, Peter Andersen, et al.
Circulation. Arrhythmia and Electrophysiology|May 7, 2020
Ablation of Reentry-Vulnerable Zones Determined by Left Ventricular Activation From Multiple Directions: A Novel Approach for Ventricular Tachycardia Ablation: A Multicenter Study (PHYSIO-VT)Elad Anter, Petr Neuzil, Vivek Y Reddy, et al.
Science (New York, N.Y.)|February 10, 2022
An autonomously swimming biohybrid fish designed with human cardiac biophysicsKeel Yong Lee, Sung-Jin Park, David G Matthews, et al.
European Heart Journal|March 19, 1999
Genetic and molecular basis of cardiac arrhythmias; impact on clinical management. Study group on molecular basis of arrhythmias of the working group on arrhythmias of the european society of cardiologyS G Priori, J Barhanin, R N Hauer, et al.
Circulation|February 9, 1999
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part IIIS G Priori, J Barhanin, R N Hauer, et al.
Circulation|February 2, 1999
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and IIS G Priori, J Barhanin, R N Hauer, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2006
Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)A D Wagner, P Buechner-Steudel, A Wein, et al.
British Journal of Cancer|November 12, 2009
Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trialsA D Wagner, P Buechner-Steudel, M Moehler, et al.
The Journal of Clinical Investigation|June 12, 2020
Auxiliary trafficking subunit GJA1-20k protects connexin-43 from degradation and limits ventricular arrhythmiasShaohua Xiao, Daisuke Shimura, Rachel Baum, et al.
Journal of Molecular and Cellular Cardiology|November 13, 2023
Determinants of electrical propagation and propagation block in Arrhythmogenic CardiomyopathyQianru Jin, Keel Yong Lee, Zoja Selimi, et al.
JCI Insight|May 13, 2016
Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathyStephen P Chelko, Angeliki Asimaki, Peter Andersen, et al.
Circulation. Arrhythmia and Electrophysiology|May 7, 2020
Ablation of Reentry-Vulnerable Zones Determined by Left Ventricular Activation From Multiple Directions: A Novel Approach for Ventricular Tachycardia Ablation: A Multicenter Study (PHYSIO-VT)Elad Anter, Petr Neuzil, Vivek Y Reddy, et al.
Science (New York, N.Y.)|February 10, 2022
An autonomously swimming biohybrid fish designed with human cardiac biophysicsKeel Yong Lee, Sung-Jin Park, David G Matthews, et al.
European Heart Journal|March 19, 1999
Genetic and molecular basis of cardiac arrhythmias; impact on clinical management. Study group on molecular basis of arrhythmias of the working group on arrhythmias of the european society of cardiologyS G Priori, J Barhanin, R N Hauer, et al.
Circulation|February 9, 1999
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part IIIS G Priori, J Barhanin, R N Hauer, et al.
Circulation|February 2, 1999
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and IIS G Priori, J Barhanin, R N Hauer, et al.
Pageof 9